Back to User profile » Mr Joseph Tkacz

Papers published by Mr Joseph Tkacz:


Benralizumab Reduces Asthma Exacerbations and Costs Among Medicare Beneficiaries with Severe Asthma: The ZEPHYR-5 Study

Adrish M, DeMartino JK, Carstens D, Jackson M, Schinkel J, Wilson K, Tkacz J

Journal of Asthma and Allergy 2026, 19:568990

Published Date: 25 March 2026

Patterns of Rescue and Maintenance Medication Claims Surrounding an Asthma Exacerbation in Patients Treated as Intermittent or Mild Persistent Asthma

Lanz MJ, Pollack M, Gilbert IA, Gandhi HN, Tkacz JP, Lugogo NL

Journal of Asthma and Allergy 2024, 17:871-877

Published Date: 14 September 2024

Exacerbations and Real-World Outcomes After Single-Inhaler Triple Therapy of Budesonide/Glycopyrrolate/Formoterol Fumarate, Among Patients with COPD: Results from the EROS (US) Study [Corrigendum]

Strange C, Tkacz J, Schinkel J, Lewing B, Agatep B, Swisher S, Patel S, Edwards D, Touchette DR, Portillo E, Feigler N, Pollack M

International Journal of Chronic Obstructive Pulmonary Disease 2024, 19:1799-1800

Published Date: 6 August 2024

Exacerbations and Real-World Outcomes After Single-Inhaler Triple Therapy of Budesonide/Glycopyrrolate/Formoterol Fumarate, Among Patients with COPD: Results from the EROS (US) Study

Strange C, Tkacz J, Schinkel J, Lewing B, Agatep B, Swisher S, Patel S, Edwards D, Touchette DR, Portillo E, Feigler N, Pollack M

International Journal of Chronic Obstructive Pulmonary Disease 2023, 18:2245-2256

Published Date: 12 October 2023

Estimating Inhaled Corticosteroid Exposure from Short-Acting β2-Agonist–Inhaled Corticosteroid Rescue

Lugogo N, Gilbert I, Pollack M, Gandhi H, Tkacz J, Lanz MJ

Journal of Asthma and Allergy 2023, 16:579-584

Published Date: 31 May 2023